Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM35W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,073
Award facts
- Contract value 100% obligated
- $22,073.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,073.28 to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Opdivo 240 mg/24 mL vials. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be completed by January 30, 2026, with the product to be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to federal agencies. The company's extensive portfolio of federal contracts demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, including oncology treatments such as Opdivo. This particular delivery order for Opdivo, an immunotherapy agent, supports the medical supply needs of military treatment facilities and federal healthcare programs served through the DLA's procurement infrastructure.
Quick answers
Who was awarded contract SPE2DR26FM35W?
SPE2DR26FM35W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM35W worth?
The government has obligated $22,073 on SPE2DR26FM35W.
Is contract SPE2DR26FM35W an order under another contract?
Yes. SPE2DR26FM35W is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM35W competed?
The extent of competition for SPE2DR26FM35W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award